PDCD1 and intrahepatic cholangiocarcinoma: The drug assay included the current first-line treatment for ICC, a combination of chemotherapy and immunotherapy, GC + checkpoint inhibitor [programmed cell death protein 1 (PD-1); 20 μg/ml].